Walking through any major airport terminal today, the evidence of a pharmaceutical revolution is impossible to ignore. Among the bustling crowds, there is a visible subset of travelers who appear…
For millions of Americans navigating the complexities of obesity and type 2 diabetes, the emergence of GLP-1 receptor agonists—such as Ozempic, Wegovy, and Zepbound—has been nothing short of a medical…
The medical landscape has been undeniably reshaped by the emergence of glucagon-like peptide-1 (GLP-1) receptor agonists. Medications such as Ozempic and Wegovy have become household names, heralded as revolutionary tools…
The landscape of obesity medicine is currently undergoing a radical transformation. For millions of people, the introduction of GLP-1 receptor agonists—such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro)—has provided…
Ammar Sabilarrohman
Dwi Wanna
Jia Lissa
Lina Irawan